rss
Br J Ophthalmol 2006;90:402-403 doi:10.1136/bjo.2005.086330
  • Editorial

Diode laser versus cryotherapy in treatment of ROP

  1. M O’Keefe and
  2. C Kirwan
  1. Mater Private Hospital, Dublin, University College Dublin, Republic of Ireland
  1. Correspondence to: Professor Michael O’Keefe Mater Private Hospital, Eccles Street, Dublin 7, Republic of Ireland; mokeefe{at}materprivate.ie

    Advantages of laser therapy

    Neonatal medicine now faces a dilemma primarily because advances in this area have reduced the age at which the fetus can survive outside the womb to as little as 23 weeks. In the United States, the approach to management of these infants is that of survival at all costs. This contrasts with the Netherlands, where a more pragmatic line is adopted, based on the high incidence of mental and physical handicap in very premature babies who survive. Paediatric ophthalmologists are faced with the challenge of screening for retinopathy of prematurity (ROP) and providing effective timely treatment to prevent blindness in infants who are frequently very sick and unstable. They must provide follow up for ongoing or anticipated ocular problems. Blindness from ROP is a significant problem, accounting for 8% of children registered in developed countries1 and 40% in developing countries.2

    Knowledge of the pathophysiology of ROP and progress in its treatment has been enormous. The 1984 classification provided an impetus for the CryoRop …

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.